NO304518B1 - Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem - Google Patents
Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter demInfo
- Publication number
- NO304518B1 NO304518B1 NO940908A NO940908A NO304518B1 NO 304518 B1 NO304518 B1 NO 304518B1 NO 940908 A NO940908 A NO 940908A NO 940908 A NO940908 A NO 940908A NO 304518 B1 NO304518 B1 NO 304518B1
- Authority
- NO
- Norway
- Prior art keywords
- benzimidazoles
- medicament
- manufacture
- pharmaceutical preparations
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK93288A DK28893D0 (da) | 1993-03-15 | 1993-03-15 | Benzimidazole derivater, deres fremstilling og anvendelse |
Publications (3)
Publication Number | Publication Date |
---|---|
NO940908D0 NO940908D0 (no) | 1994-03-14 |
NO940908L NO940908L (no) | 1994-09-16 |
NO304518B1 true NO304518B1 (no) | 1999-01-04 |
Family
ID=8091872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940908A NO304518B1 (no) | 1993-03-15 | 1994-03-14 | Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem |
Country Status (14)
Country | Link |
---|---|
US (1) | US5475015A (no) |
EP (1) | EP0617023B1 (no) |
JP (1) | JP3748901B2 (no) |
KR (1) | KR100300800B1 (no) |
AT (1) | ATE172453T1 (no) |
AU (1) | AU679023B2 (no) |
CA (1) | CA2118997C (no) |
DE (1) | DE69414017T2 (no) |
DK (2) | DK28893D0 (no) |
ES (1) | ES2123741T3 (no) |
FI (1) | FI941214A (no) |
NO (1) | NO304518B1 (no) |
NZ (1) | NZ260049A (no) |
ZA (1) | ZA941816B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
JP2003506355A (ja) * | 1999-08-03 | 2003-02-18 | アボット・ラボラトリーズ | カリウムチャンネル開放剤 |
DE10209520A1 (de) * | 2002-03-04 | 2003-09-25 | 4Sc Ag | Neue Modulatoren von Kaliumkanälen |
EP1519923A1 (en) * | 2002-06-26 | 2005-04-06 | Poseidon Pharmaceuticals A/S | Novel benzimidazol-2-one derivatives and their use |
WO2005035498A1 (ja) * | 2003-10-08 | 2005-04-21 | Dainippon Sumitomo Pharma Co., Ltd. | 含窒素二環性化合物の摂食調節剤としての用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ239540A (en) * | 1990-09-24 | 1993-11-25 | Neurosearch As | 1-phenyl benzimidazole derivatives and medicaments |
US5200422A (en) * | 1990-09-24 | 1993-04-06 | Neurosearch A/S | Benzimidazole derivatives, their preparation and use |
-
1993
- 1993-03-15 DK DK93288A patent/DK28893D0/da not_active Application Discontinuation
-
1994
- 1994-03-02 AU AU56492/94A patent/AU679023B2/en not_active Ceased
- 1994-03-04 US US08/206,506 patent/US5475015A/en not_active Expired - Lifetime
- 1994-03-08 NZ NZ260049A patent/NZ260049A/en not_active IP Right Cessation
- 1994-03-11 EP EP94610013A patent/EP0617023B1/en not_active Expired - Lifetime
- 1994-03-11 ES ES94610013T patent/ES2123741T3/es not_active Expired - Lifetime
- 1994-03-11 DE DE69414017T patent/DE69414017T2/de not_active Expired - Fee Related
- 1994-03-11 AT AT94610013T patent/ATE172453T1/de not_active IP Right Cessation
- 1994-03-11 DK DK94610013T patent/DK0617023T3/da active
- 1994-03-14 CA CA002118997A patent/CA2118997C/en not_active Expired - Fee Related
- 1994-03-14 KR KR1019940004982A patent/KR100300800B1/ko not_active IP Right Cessation
- 1994-03-14 NO NO940908A patent/NO304518B1/no unknown
- 1994-03-14 JP JP04275094A patent/JP3748901B2/ja not_active Expired - Fee Related
- 1994-03-15 FI FI941214A patent/FI941214A/fi unknown
- 1994-03-15 ZA ZA941816A patent/ZA941816B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK28893D0 (da) | 1993-03-15 |
DE69414017D1 (de) | 1998-11-26 |
ES2123741T3 (es) | 1999-01-16 |
US5475015A (en) | 1995-12-12 |
FI941214A0 (fi) | 1994-03-15 |
DE69414017T2 (de) | 1999-04-08 |
FI941214A (fi) | 1994-09-16 |
NO940908D0 (no) | 1994-03-14 |
AU679023B2 (en) | 1997-06-19 |
ZA941816B (en) | 1995-10-13 |
EP0617023B1 (en) | 1998-10-21 |
JP3748901B2 (ja) | 2006-02-22 |
NO940908L (no) | 1994-09-16 |
ATE172453T1 (de) | 1998-11-15 |
CA2118997A1 (en) | 1994-09-16 |
KR100300800B1 (ko) | 2001-11-22 |
EP0617023A1 (en) | 1994-09-28 |
AU5649294A (en) | 1994-09-22 |
KR940021534A (ko) | 1994-10-19 |
JPH06321910A (ja) | 1994-11-22 |
NZ260049A (en) | 1996-03-26 |
CA2118997C (en) | 2002-05-28 |
DK0617023T3 (da) | 1999-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9203543A (es) | Medicamento. | |
DE3382458D1 (de) | Haarwuchsmittel. | |
NL300382I1 (nl) | Treatment of pompe's disease | |
FI870219A (fi) | Hypoglykemiska tiazolidindioner. | |
BR9808938A (pt) | Composto, composição farmacêutica, uso de um composto, processos para o tratamento de um distúrbio ou doença de um corpo de animal vivo e para a preparação de um composto, e, uso de bloqueadores de canal de cloreto | |
BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
PT920865E (pt) | Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos | |
FR2713637B1 (fr) | Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
SE8404283L (sv) | Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar | |
NO172043C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater | |
NO304518B1 (no) | Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem | |
BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
ATE185274T1 (de) | Therapeutisches mittel gegen drohenden abortus | |
NO173137C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser | |
DE3877499D1 (de) | 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet. | |
ATE74354T1 (de) | N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
KR910018026A (ko) | α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제 | |
UA30143A (uk) | Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань | |
KR890000089A (ko) | 신장 질환 치료제 | |
NO20082302L (no) | Anvendelse av et pleuromutilinderivat innen vetrinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen |